aTyr Pharma, Inc. (ATYR) Earnings
|
Expand Research on ATYR
| Next EPS Date | 11/5/26 | EPS Growth Rate | +61.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -3.1% | Revenue Growth Rate | -100.0% |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/26 |
Q226 | -$0.11 | -$0.12 | +$0.01 | N/A | N/A | N/A |  | | Details | |
| 5/13/26 |
Q126 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/12/26 |
Q425 | N/A | -$0.18 | N/A | N/A | $25K | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$0.26 | -$0.17 | -$0.09 | $190K | $1.33M | N/A | | | Details | |
| 8/13/25 |
Q225 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/25 | Q125 | -$0.17 | -$0.19 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 3/13/25 | Q424 | -$0.18 | -$0.23 | +$0.05 | N/A | N/A | N/A | | | Details |
